Vascular hyperpermeability, angiogenesis, and stroma generation

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 2, 2012, Pages

  Nagy, Janice A ^a   Dvorak, Ann M ^a   Dvorak, Harold F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CAVEOLIN 1; CYSTEINE PROTEINASE; FERRITIN; FIBRIN; FIBRINOGEN; FIBRONECTIN; HORSERADISH PEROXIDASE; OSTEOPONTIN; PROTHROMBIN; VASCULOTROPIN A; VITRONECTIN; BLOOD CLOTTING FACTOR; IMMUNOGLOBULIN; SERUM ALBUMIN; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CANCER PROGNOSIS; CELL MIGRATION; DIFFUSION; ENDOTHELIUM CELL; FIBROBLAST; GLIOBLASTOMA; GRANULATION TISSUE; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERICYTE; PROTEIN DEGRADATION; SCAR FORMATION; STROMA; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR HYPERPERMEABILITY; BIOASSAY; CAPILLARY PERMEABILITY; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NOMENCLATURE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STROMA CELL; VASCULARIZATION; VENULE;

BIOLOGICAL ASSAY; BLOOD COAGULATION FACTORS; CAPILLARY PERMEABILITY; FIBRONECTINS; HUMANS; IMMUNOGLOBULINS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SERUM ALBUMIN; STROMAL CELLS; TERMINOLOGY AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENULES;

EID: 84878962706     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006544     Document Type: Article

References (64)

1. Bates DO, Harper SJ. 2003. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39: 225-237.
2. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. 1998. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J Exp Med 188: 1135-1145.
3. Brown LF, Lanir N, McDonagh J, Czarnecki K, Estrella P, Dvorak AM, Dvorak HF. 1993. Fibroblast migration in fibrin gel matrices. Am J Pathol 142: 273-283.
4. Chalupowicz DG, Chowdhury ZA, Bach TL, Barsigian C, Martinez J. 1995. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 130: 207-215.
5. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO. 2004. Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol 2: E7. doi: 10. 1371/journal. pbio. 0020007.
6. Chang SH, Feng D, Nagy JA, Sciuto TE, Dvorak AM, Dvorak HF. 2009a. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol 175: 1768-1776.
7. Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, NagyJA, Joyce J, Bogyo M, et al. 2009b. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res 69: 4537-4544.
8. Curry FR. 2005. Microvascular solute and water transport. Microcirculation 12: 17-31.
9. Dvorak HF. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
10. Dvorak HF. 2003. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 162: 1747-1757.
11. Dvorak A. 2007a. Electron microscopic-facilitated understanding of endothelial cell biology: Contributions established during the 1950s and 1960s. In Endothelial biomedicine (ed. Aird W.), pp. 643-656. Cambridge University Press, New York.
12. Dvorak H. 2007b. Tumor blood vessels. In Endothelial biomedicine (ed. AirdW.), pp. 1457-1470. Cambridge University Press, New York.
13. Dvorak HF, Rickles FR. 2006. Hemostasis and thrombosis in cancer. InHemostasis and thrombosis: Basic principles and clinical practice (ed. ColmanRW, Marder VJ, Clowes AW, et al.), pp. 851-873. Lippincott Williams & Wilkins, Philadelphia.
14. Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH. 1979a. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst 62: 1459-1472.
15. Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM, Rypysc J, Giovinco P. 1979b. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 122: 166-174.
16. Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, CarvalhoAC. 1981. Tumor shedding and coagulation. Science 212: 923-924.
17. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. 1987. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57: 673-686.
18. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. 1988. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133: 95-109.
19. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF. 1996. The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59: 100-115.
20. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. 1996. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183: 1981-1986.
21. Feng D, Nagy JA, Hipp J, Pyne K, Dvorak HF, Dvorak AM. 1997. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse, and rat: Many are transcellular pores. J Physiol 504: 747-761.
22. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. 1998. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 187: 903-915.
23. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. 1999a. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 6: 23-44.
24. Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, Caldwell RB. 1999b. VEGF-induced permeability increase is mediated by caveolae. Invest Ophthalmol Vis Sci 40: 157-167.
25. Feng D, Nagy J, Dvorak A, Dvorak H. 2000. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res 59: 24-37.
26. Galli SJ. 2000. Mast cells and basophils. Curr Opin Hematol 7: 32-39.
27. Goffin JR, Straume O, Chappuis PO, Brunet JS, Begin LR, Hamel N, Wong N, Akslen LA, Foulkes WD. 2003. Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer. Br J Cancer 89: 1031-1034.
28. Guyton A, Hall J. 2000. Textbook of medical physiology. Saunders, Philadelphia.
29. Haddow A. 1974. Addendum to "Molecular repair, wound healing, and carcinogenesis: Tumor production a possible overhealing?" Adv Cancer Res 20: 343-366.
30. Hashimoto-Uoshimka M, Zhuo Yan Y, Schneider G, Aukhil I. 1997. The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading. J Cell Sci 110: 2271-2280.
31. Hauptmann S, Zardi L, Siri A, Carnemolla B, Borsi L, Castellucci M, Klosterhalfen B, Hartung P, Weis J, Stocker G, et al. 1995. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest 73: 172-182.
32. Hynes RO. 2009. The extracellular matrix: Not just pretty fibrils. Science 326: 1216-1219.
33. Joshi P, Chung CY, Aukhil I, Erickson HP. 1993. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Sci 106: 389-400.
34. Kamei M, Carman CV. 2010. New observations on the trafficking and diapedesis of monocytes. Curr Opin Hematol 17: 43-52.
35. Karnovsky MJ. 1967. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol 35: 213-236.
36. Kohn S, Nagy JA, Dvorak HF, Dvorak AM. 1992. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 67: 596-607.
37. Majno G, Palade GE, Schoefl GI. 1961. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: A topographic study. J Biophys Biochem Cytol 11: 607-626.
38. Majno G, Shea SM, Leventhal M. 1969. Endothelial contraction induced by histamine-type mediators: An electron microscopic study. J Cell Biol 42: 647-672.
39. McDonald DM, Thurston G, Baluk P. 1999. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 6: 7-22.
40. Michel CC, Curry FE. 1999. Microvascular permeability. Physiol Rev 79: 703-761.
41. Miles AA, Miles EM. 1952. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 118: 228-257.
42. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF. 1995. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55: 360-368.
43. Nagy JA, Feng D, Vasile E, Wong WH, Shih SC, Dvorak AM, Dvorak HF. 2006. Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest 86: 767-780.
44. Nagy JA, Dvorak AM, Dvorak HF. 2007. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2: 251-275.
45. Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. 2008a. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11: 109-119.
46. Nagy JA, Shih SC, Wong WH, Dvorak AM, Dvorak HF. 2008b. The adenoviral vector angiogenesis/lymphangiogenesis assay. Methods Enzymol 444: 43-64.
47. Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. 2010. Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36: 321-331.
48. Neal CR, Michel CC. 1995. Transcellular gaps in microvascular walls of frog and rat when permeability is increased by perfusion with the ionophore A23187. J Physiol 488: 427-437.
49. Palade G. 1988. The microvascular endothelium revisited. In Endothelial cell biology in health and disease (ed. Simionescu N, Simionescu M), pp. 3-22. Plenum Press, New York.
50. Pappenheimer JR. 1953. Passage of molecules through capillary walls. Physiol Rev 33: 387-423.
51. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, et al. 2000. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80: 99-115.
52. Rippe B, Haraldsson B. 1994. Transport of macromolecules across microvascular walls: The two-pore theory. Physiol Rev 74: 163-219.
53. Roberts WG, Palade GE. 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379.
54. Rosengren BI, Rippe A, Rippe C, Venturoli D, Sward K, Rippe B. 2006. Transvascular protein transport in mice lacking endothelial caveolae. Am J Physiol Heart Circ Physiol 291: H1371-H1377.
55. Sage EH. 1997. Terms of attachment: SPARC and tumorigenesis. Nat Med 3: 144-146.
56. -/- knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277: 40091-40098.
57. Senger DR. 1996. Molecular framework for angiogenesis: A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 149: 1-7.
58. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
59. Stan RV. 2007. Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J Cell Mol Med 11: 621-643.
60. Straume O, Chappuis PO, Salvesen HB, Halvorsen OJ, Haukaas SA, Goffin JR, Begin LR, Foulkes WD, Akslen LA. 2002. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res 62: 6808-6811.
61. Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, DvorakAM, Dvorak HF. 2001. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158: 1145-1160.
62. Swayne GT, Smaje LH, Bergel DH. 1989. Distensibility of single capillaries and venules in the rat and frog mesentery. Int J Microcirc Clin Exp 8: 25-42.
63. VanDeWater L, Tracy PB, Aronson D, Mann KG, Dvorak HF. 1985. Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res 45: 5521-5525.
64. Yeo TK, Brown L, Dvorak HF. 1991. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol 138: 1437-1450.